Access campaign
MSF challenges Gilead’s patent application for hepatitis C combination treatment in China, to bring down...
December 15, 2017 | China
Access campaign
MSF secures generic hepatitis C treatment at $120 compared to $147,000 launch price tag
October 31, 2017 |
Access campaign
MSF approaches Delhi High Court to challenge unmerited patent grant for pneumonia vaccine
October 13, 2017 | India
Access campaign
RCEP negotiators must fix the damaging provisions that remain a threat to public health
July 21, 2017 | India
Access campaign
Child-Friendly Formulation of WHO-Recommended HIV Treatment Now Approved by the CDSCO
June 6, 2017 | India
Access campaign
MSF response on upcoming RCEP negotiations in the Philippines
May 8, 2017 | Philippines
Access campaign
Investors join MSF in calling Pfizer to Reduce the price of vaccine against top childhood...
April 27, 2017 |
Access campaign
Health groups call on Government of India to urgently make lifesaving TB drug available
January 30, 2017 | India
Access campaign
Briefing: Trading Away Health – The Regional Comprehensive Economic Partnership
December 6, 2016 |
Access campaign
MSF welcomes Pfizer’s pneumonia vaccine price reduction for children in humanitarian emergencies
November 25, 2016 |
